MBX Biosciences (MBX) Other Non-Current Assets (2023 - 2026)

MBX Biosciences has disclosed Other Non-Current Assets across 4 years of filings, most recently posting $42000.0 for Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $42000.0, down 16.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $42000.0 (down 16.0% YoY), and the FY2023 annual result was $50000.0, changed N/A from the prior year.
• Other Non-Current Assets came in at $42000.0 for Q1 2026 at MBX Biosciences, down from $50000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $50000.0 in Q4 2023 to a low of $42000.0 in Q1 2026.
• The 4-year median for Other Non-Current Assets is $50000.0 (2023), against an average of $48666.7.
• Across the five-year window, Other Non-Current Assets changed 0.0% in 2025 and fell 16.0% in 2026, its largest moves.
• MBX Biosciences' Other Non-Current Assets stood at $50000.0 in 2023, then changed by 0.0% to $50000.0 in 2024, then changed by 0.0% to $50000.0 in 2025, then dropped by 16.0% to $42000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $42000.0 (Q1 2026), $50000.0 (Q3 2025), and $50000.0 (Q2 2025), per Business Quant data.